2011
DOI: 10.1021/np200232s
|View full text |Cite
|
Sign up to set email alerts
|

Antinociceptive Properties of Bergenin

Abstract: Bergenin (1) is a C-glucoside of 4-O-methylgallic acid with known antiarthritic activity attributed to modulation of cytokine production. The present study was undertaken to evaluate whether 1 has antinociceptive properties in models of inflammatory pain and to investigate its possible mechanisms of action. Pretreatment with 1 (12.5-100 mg/kg, ip) produced a dose-related inhibition of acetic acid-induced writhing in mice. Furthermore, treatment with 1 (50 and 100 mg/kg) inhibited both the early and late phases… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
30
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(32 citation statements)
references
References 47 publications
2
30
0
Order By: Relevance
“…Following, the first phase or early phase, there is the beginning of the late or secondary phase, which results from local inflammation and release of inflammatory mediators. This phase is referred to as the inflammatory phase and lasts between 20 and 30 min (de Oliveira et al, ). Thirty animals were randomly divided into five groups such as negative control (only formalin treated), positive control (piroxicam 5 mg/kg, i.p), and treatment control administering 25‐MHA at the doses of 1, 5, and 10 mg/kg, and each group treated was assigned six animals.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Following, the first phase or early phase, there is the beginning of the late or secondary phase, which results from local inflammation and release of inflammatory mediators. This phase is referred to as the inflammatory phase and lasts between 20 and 30 min (de Oliveira et al, ). Thirty animals were randomly divided into five groups such as negative control (only formalin treated), positive control (piroxicam 5 mg/kg, i.p), and treatment control administering 25‐MHA at the doses of 1, 5, and 10 mg/kg, and each group treated was assigned six animals.…”
Section: Methodsmentioning
confidence: 99%
“…The antinociceptive potential of 25‐MHA (10 mg/kg, i.p) was also investigated against the acetic acid‐induced visceral pain, known as the writhing test. The acetic acid following administration into the peritoneum of the mice produces writhing movement characterised by abdominal contraction with hind paw extension (de Oliveira et al, ). Eighteen mice were randomly divided into three groups ( n = 6 per group) such as negative control (administered with acetic acid only), positive control (piroxicam 5 mg/kg, i.p), and treatment control that received 25‐MHA (10 mg/kg, i.p).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…2 Our finding of bergenin and its derivatives as potent IL-6 inhibitors is in agreement with the recent report on antinociception activity of bergenin. 25 Because RA is a chronic inflammatory disease and the joint pain is one of the key pathological symptoms, the antinociceptive agents will have additional beneficial effects in disease management. On the basis of this, we decided to investigate antiarthritic effect of bergenin and potent derivatives 4e and 4f in animal models.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…It exhibits various biological activities, such as antioxidant 27,28 , anti-inflammatory 29 , anti-arthritis 30 , hypolipidemic 31 , anti-HIV 32 , antiarrhythmic 33 , hepatoprotective 34 , and antinociceptive effects 35 . Bergenin contains 5 hydroxyl groups, which are considered to be potentially active.…”
mentioning
confidence: 99%